Published in Law and Health Weekly, March 27th, 2010
"We're excited that XIAFLEX is now available to Dupuytren's contracture patients after many years of hard work," said Thomas Wegman, President of BioSpecifics. "In addition our shareholders will benefit as we begin to receive royalties, as well as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.